Breaking Down the 2026 Consolidated Appropriations Act and Its Impact on Specialty Pharmacy | NASP Specialty Pharmacy Podcast
About this episode
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Duane Morris Pharmacy Litigation Group Chair, and Bradley A. Wasser, Duane Morris Pharmacy Litigation Group Partner. They discuss the 2026 Consolidated Appropriations Act and its landmark PBM reform provisions that impact pharmacy network access and transparency. These expert litigators go into detail about what specialty pharmacies should expect as federal agencies enforce the new law and what opportunities and challenges lie ahead for specialty pharmacies.
Get every episode summarized
Each time Pharmacy Podcast Network publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Pharmacy Podcast Network
Thug Drugs: Psychedelic Studies | Pain Pod
Pharmacy Podcast Network
Beyond Dispensing: Building a Pharmacy Around Medication Management and Communit...
Pharmacy Podcast Network
More Patients, Same Pharmacists: Preparing Independent Pharmacy for the Next Era...
Pharmacy Podcast Network
Inventory, AI and Automation, R&D Tax Credits, Peptides, and Basis | The Bottom...
Pharmacy Podcast Network